TABLE 4.
Crude incidence rates of the metabolic syndrome (MetS) by changes in components of the MetS and bodyweight
| Changes in bodyweight and MetS components during follow-up |
Incident cases of MetS/1000 person-y IR and 95% CI limits |
||||
|---|---|---|---|---|---|
| n | Person-y | IR | Lower, upper limits |
P value for trend |
|
| Fasting plasma glucosea (mg/dL) | < .001 | ||||
| First quartile (−41 to 2) | 39 | 5545 | 7.0 | 4.8, 9.2 | |
| Second quartile (3–9) | 47 | 6326 | 7.4 | 5.3, 9.5 | |
| Third quartile (10–16) | 51 | 7333 | 7.0 | 5.1, 8.9 | |
| Fourth quartile (17–217) | 122 | 6042 | 20.2 | 16.6, 23.8 | |
| Plasma HDL-Ca (mg/dL) | < .001 | ||||
| First quartile (−50 to −8) | 127 | 5681 | 22.4 | 18.5, 26.3 | |
| Second quartile (−7 to 0) | 91 | 6294 | 14.5 | 11.5, 17.5 | |
| Third quartile (1–9) | 32 | 6536 | 4.9 | 3.2, 6.6 | |
| Fourth quartile (10–70) | 9 | 6735 | 1.3 | 0.4, 2.2 | |
| Waist girtha (cm) | < .001 | ||||
| First quartile (−37.5 to 5.0) | 12 | 6084 | 2.0 | 0.9, 3.1 | |
| Second quartile (5.1–11.7) | 23 | 6399 | 3.6 | 2.1, 5.1 | |
| Third quartile (11.8–19.3) | 71 | 6361 | 11.2 | 8.6,13.8 | |
| Fourth quartile (19.3–65.0) | 153 | 6402 | 23.9 | 20.1, 27.7 | |
| Bodyweight (kg)a,b | < .001 | ||||
| First quartile (−45.4 to 4.4) | 6 | 6277 | 1.0 | 0.2, 1.7 | |
| Second quartile (4.5–11.3) | 27 | 6391 | 4.2 | 2.6, 5.8 | |
| Third quartile (11.4–21.5) | 74 | 6270 | 11.8 | 9.1, 14.5 | |
| Fourth quartile (21.6–80.7) | 152 | 6288 | 24.2 | 20.3, 28.0 | |
CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; IR, incidence rates; MetS, metabolic syndrome; n, number of new cases of MetS.
a
Change
b
1 woman missing weight change (noncase).